XBiotech (XBIT) EV to CFO (2021 - 2022)
XBiotech's (XBIT) EV to CFO was 0.50 for Q1 2022, down 66.0% from the prior quarter.
Powered by 
Analysis
XBiotech (XBIT) EV to CFO (2021 - 2022) Analysis & Trends
Over the twelve months ended Mar 31, 2022, XBiotech's EV to CFO came in at -12.16; for FY2021, it came in at 1.47.
- Per Business Quant data, the three quarters before Q1 2022 came in at 1.47 (Q4 2021), 2.19 (Q3 2021) and 2.23 (Q2 2021).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,156.48 Bn | 1,125.07 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 623.52 Bn | 542.04 Bn | 17.26 Bn |
| 3 | AbbVie | 511.52 Bn | 484.64 Bn | 12.70 Bn |
| 4 | Merck | 366.08 Bn | 320.46 Bn | 12.21 Bn |
| 5 | Novartis Ag | 297.10 Bn | 261.09 Bn | 11.24 Bn |
| 6 | Astrazeneca | 260.97 Bn | 234.66 Bn | 12.86 Bn |
| 7 | Amgen | 234.36 Bn | 189.76 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 193.20 Bn | 167.40 Bn | 6.22 Bn |
| 9 | Pfizer | 171.61 Bn | 118.26 Bn | 10.94 Bn |
| 10 | XBiotech | 61.28 Mn | -474.14 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2022 | 0.50 |
| Dec 31, 2021 | 1.47 |
| Sep 30, 2021 | 2.19 |
| Jun 30, 2021 | 2.23 |
API Access
XBiotech EV to CFO API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ev-to-cfo&ticker=XBIT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ev-to-cfo", "ticker": "XBIT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ev-to-cfo&ticker=XBIT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();